Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.
Elad Kedar
Advertisement
Articles by Elad Kedar
Orasis Pharmaceuticals drop in development for treating presbyopia
Advertisement
Latest Updated Articles
Pipeline: Presbyopia treatment to finish Phase 3 late 2021Published: June 4th 2021 | Updated:
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in GA
2
Ortho-k: More than meets the eye to control myopia progression
3
Crafting your own eyewear brand: Streamlining the private label process
4
Drs Kaleb Abbott, Andrew Pucker suggest changing "artificial tear" terminology
5
.png "Optometry Times"){kind=logo}
